%0 Journal Article
%T AZD8055 Is a Potent, Selective, and Orally Bioavailable ATP-Competitive Mammalian Target of Rapamycin Kinase Inhibitor with <i>In vitro</i> and <i>In vivo</i> Antitumor Activity
%A Chresta, Christine M.
%A Davies, Barry R.
%A Hickson, Ian
%A Harding, Tom
%A Cosulich, Sabina
%A Critchlow, Susan E.
%A Vincent, John P.
%A Ellston, Rebecca
%A Jones, Darren
%A Sini, Patrizia
%A James, Dominic
%A Howard, Zoe
%A Dudley, Phillippa
%A Hughes, Gareth
%A Smith, Lisa
%A Maguire, Sharon
%A Hummersone, Marc
%A Malagu, Karine
%A Menear, Keith
%A Jenkins, Richard
%A Jacobsen, Matt
%A Smith, Graeme C.M.
%A Guichard, Sylvie
%A Pass, Martin
%A ,
%J Cancer Research
%@ 0008-5472
%D 2010-01-01
%I American Association for Cancer Research (AACR)
%~ DeepDyve